Skip to main content
NCBI home page
Springer logoLink to Springer
. 2017 Sep 26;60(12):2540. doi: 10.1007/s00125-017-4446-5

Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet

Manuela Battaglia 1,✉, Mark S Anderson 2, Jane H Buckner 3, Susan M Geyer 4, Peter A Gottlieb 5, Thomas W H Kay 6,7, Åke Lernmark 8, Sarah Muller 4, Alberto Pugliese 9, Bart O Roep 10,11, Carla J Greenbaum 12, Mark Peakman 13,14,15,✉
PMCID: PMC6828087  PMID: 28948305

Erratum to: Diabetologia

10.1007/s00125-017-4384-2

An editorial change altered the meaning of a sentence in this review, implying that TrialNet only started conducting clinical trials in 2016. The sentence should have read: ‘At the time of writing (2016), TrialNet is conducting clinical trials with researchers from 18 clinical centres in the USA, Canada, Finland, UK, Italy, Germany, Sweden, Australia and New Zealand’.

Footnotes

The online version of the original article can be found at 10.1007/s00125-017-4384-2

Contributor Information

Manuela Battaglia, Email: battaglia.manuela@hsr.it.

Mark Peakman, Email: mark.peakman@kcl.ac.uk.

Articles from Diabetologia are provided here courtesy of Springer

RESOURCES